In His Latest PharmExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.

Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company

by Amit Chowdhry of Pulse 2.0

A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes

Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)

by Tori Whitacre Martonicz of Infection Control Today

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)

by Sophia Abene of Contagion Live

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Virax Biolabs Presents at H.C. Wainwright’s 26th Annual Global Investment Conference